Results 11 to 20 of about 18,795 (133)

Anticipating impact of implementing PCV20 or PCV21 vaccines for older adults in the immunisation programme for invasive pneumococcal disease, using nationwide surveillance data, Israel, 2009 to 2024 [PDF]

open access: yesEurosurveillance
BACKGROUND Pneumococcal conjugate vaccines (PCVs) have reduced vaccine-type (VT) invasive pneumococcal disease (IPD) in older adults through direct and indirect effects. However, non-vaccine-type serotypes have emerged.
on behalf of the Israeli Adult Pneumococcal Invasive Disease (IAIPD) group
doaj   +2 more sources

Invasive pneumococcal disease presenting with abdominal pain, vomiting and diarrhoea in a patient with multiple myeloma [PDF]

open access: yesEuropean Journal of Case Reports in Internal Medicine
Background: Streptococcus pneumoniae is a leading cause of community-acquired pneumonia and meningitis, but intra-abdominal manifestations are rare, particularly in adults without underlying peritoneal disease.
Hélder Diogo Gonçalves   +6 more
doaj   +2 more sources

Pneumococcal serotypes and their association with death risk in invasive pneumococcal disease: a systematic review and meta-analysis

open access: yesFrontiers in Medicine
BackgroundStreptococcus pneumoniae and its infections are a global public health concern. Invasive pneumococcal disease accounts for significant mortality in the aged and immunocompromised. Over 100 unique capsular serotypes have been identified, with 80–
Samuel Darkwah   +3 more
doaj   +3 more sources

A Retrospective Analysis to Estimate the Burden of Invasive Pneumococcal Disease and Non-Invasive Pneumonia in Children <15 Years of Age in the Veneto Region, Italy

open access: yesChildren, 2022
Despite advances in preventative interventions, invasive pneumococcal disease and pneumonia cause significant morbidity and mortality in children. We studied the annual incidence of pneumococcal-specific and syndromic invasive disease and non-invasive ...
Elisa Barbieri   +9 more
doaj   +1 more source

INVASIVE PNEUMOCOCCAL DISEASES IN CHILDREN AGED 1-59 MONTHS IN SICILY, ITALY: IMPORTANCE OF ACTIVE FAMILY PAEDIATRICIAN SURVEILLANCE AND VACCINATION COVERAGE. [PDF]

open access: yesEuromediterranean Biomedical Journal, 2014
Purpose: Aim of this study was to analyze pediatric invasive pneumococcal disease rates several years after the implementation of infant pneumococcal vaccination. Methods: The study was carried out in Sicily and involved about 30,000 children, aged 1-
Emanuele Amodio
doaj   +1 more source

Will Extended-Valency Pneumococcal Conjugate Vaccines Offer Enhanced Coverage Against Invasive Pneumococcal Disease for At-Risk Children? [PDF]

open access: yesActa Paediatr
Acta Paediatrica, Volume 115, Issue 11, Page 2640-2643, November 2026.
Cohen R   +8 more
europepmc   +2 more sources

Population-based analysis of invasive nontypeable pneumococci reveals that most have defective capsule synthesis genes. [PDF]

open access: yesPLoS ONE, 2014
Since nasopharyngeal carriage of pneumococcus precedes invasive pneumococcal disease, characteristics of carriage isolates could be incorrectly assumed to reflect those of invasive isolates.
In Ho Park   +4 more
doaj   +1 more source

Intrafamilial Transmission of Pneumococcal Acute Spontaneous Peritonitis

open access: yesInfectious Disease Reports, 2023
Streptococcus pneumonia (S. pneumoniae, Pneumococcus) is a major cause of childhood morbidity and mortality worldwide. The most common presentations of invasive pneumococcal disease (IPD) in children include bacteremic pneumonia, meningitis, and ...
Ioanna Papadatou   +5 more
doaj   +1 more source

Optimising assessments of the epidemiological impact in The Netherlands of paediatric immunisation with 13-valent pneumococcal conjugate vaccine using dynamic transmission modelling. [PDF]

open access: yesPLoS ONE, 2014
This work is the first attempt to quantify the overall effects of a 13-valent pneumococcal conjugate vaccine (PCV13) vaccination programme in the Dutch population taking into account all the direct and indirect effects of the vaccine on invasive ...
Elisabetta De Cao   +3 more
doaj   +1 more source

Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006–18: prospective observational time-series and case-control studies

open access: yesThe Lancet Global Health, 2021
Summary: Background: The population impact of pneumococcal conjugate vaccines (PCVs) depends on direct and indirect protection. Following Malawi's introduction of the 13-valent PCV (PCV13) in 2011, we examined its impact on vaccine and non-vaccine ...
Naor Bar-Zeev, PhD   +16 more
doaj   +1 more source

Home - About - Disclaimer - Privacy